Full name
LUBEA MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
72 - Scientific research and development activities
85 - Education
86 - Healthcare
88 - Social assistance without accommodation
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -55,6 | 21,1 | 137,9 |
EBITDA | -55,6 | 20,6 | 137,1 |
Short time liabilities | 115,1 | 165,6 | 43,8 |
Equity capital | -50,6 | -29,5 | 41,6 |
Operating profit (EBIT) | -55,6 | 20,6 | 137,1 |
Assets | 64,5 | 161,1 | 149,5 |
Net profit (loss) | -55,6 | 21,1 | 137,9 |
Cash | 9,3 | 64,3 | 590,1 |
Net income from sale | 48 | 611,4 | 1174,5 |
Liabilities and provisions for liabilities | 115,1 | 190,6 | 65,5 |
Working assets | 64,5 | 161,1 | 149,5 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 109,9 | -71,4 | -181,3 |
Equity capital to total assets | -78,4 | -18,3 | 60,1 |
Gross profit margin | -115,9 | 3,4 | 119,3 |
EBITDA Margin | -115,9 | 3,4 | 119,3 |
Days | Days | Days | |
Short term commitment turnover cycle | 876 | 99 | -777 |
Current financial liquidity indicator | 0.5605322122573853 | 0.8450649380683899 | 0,2 |
Net dept to EBITDA | -0.640137791633606 | -3.1164331436157227 | -2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane